Download presentation
Presentation is loading. Please wait.
Published byAlan Shelton Modified over 6 years ago
1
A. Schema of NSABP B-27 trial comparing neoadjuvant AC to neoadjuvant AC followed by neoadjuvant docetaxel and to neoadjuvant AC followed by adjuvant docetaxel in patients with operable breast cancer. B. Comparison of disease-free survival by treatment and pCR. (Tam, tamoxifen.) Source: Chapter 42. The NSABP Experience, Kuerer's Breast Surgical Oncology Citation: Kuerer HM. Kuerer's Breast Surgical Oncology; 2010 Available at: Accessed: October 13, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.